• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士一家大学医院中感染 SARS-CoV-2 的患者的流行病学、风险因素和临床病程:一项观察性回顾性研究。

Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.

机构信息

Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Service of Hospital Preventive Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

PLoS One. 2020 Nov 13;15(11):e0240781. doi: 10.1371/journal.pone.0240781. eCollection 2020.

DOI:10.1371/journal.pone.0240781
PMID:33186355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665644/
Abstract

BACKGROUND

This study aims to describe the epidemiology of COVID-19 patients in a Swiss university hospital.

METHODS

This retrospective observational study included all adult patients hospitalized with a laboratory confirmed SARS-CoV-2 infection from March 1 to March 25, 2020. We extracted data from electronic health records. The primary outcome was the need to mechanical ventilation at day 14. We used multivariate logistic regression to identify risk factors for mechanical ventilation. Follow-up was of at least 14 days.

RESULTS

145 patients were included in the multivariate model, of whom 36 (24.8%) needed mechanical ventilation at 14 days. The median time from symptoms onset to mechanical ventilation was 9·5 days (IQR 7.00, 12.75). Multivariable regression showed increased odds of mechanical ventilation with age (OR 1.09 per year, 95% CI 1.03-1.16, p = 0.002), in males (OR 6.99, 95% CI 1.68-29.03, p = 0.007), in patients who presented with a qSOFA score ≥2 (OR 7.24, 95% CI 1.64-32.03, p = 0.009), with bilateral infiltrate (OR 18.92, 3.94-98.23, p<0.001) or with a CRP of 40 mg/l or greater (OR 5.44, 1.18-25.25; p = 0.030) on admission. Patients with more than seven days of symptoms on admission had decreased odds of mechanical ventilation (0.087, 95% CI 0.02-0.38, p = 0.001).

CONCLUSIONS

This study gives some insight in the epidemiology and clinical course of patients admitted in a European tertiary hospital with SARS-CoV-2 infection. Age, male sex, high qSOFA score, CRP of 40 mg/l or greater and a bilateral radiological infiltrate could help clinicians identify patients at high risk for mechanical ventilation.

摘要

背景

本研究旨在描述瑞士一家大学医院 COVID-19 患者的流行病学特征。

方法

这是一项回顾性观察性研究,纳入了 2020 年 3 月 1 日至 3 月 25 日期间因实验室确诊的 SARS-CoV-2 感染而住院的所有成年患者。我们从电子病历中提取数据。主要结局为 14 天内需要机械通气。我们使用多变量逻辑回归来确定机械通气的危险因素。随访时间至少为 14 天。

结果

共纳入 145 例患者进行多变量模型分析,其中 36 例(24.8%)在 14 天内需要机械通气。症状发作至机械通气的中位时间为 9.5 天(IQR 7.00,12.75)。多变量回归显示,年龄每增加 1 岁,机械通气的可能性增加 1.09(95%CI 1.03-1.16,p = 0.002),男性(OR 6.99,95%CI 1.68-29.03,p = 0.007),qSOFA 评分≥2 分(OR 7.24,95%CI 1.64-32.03,p = 0.009),双侧浸润(OR 18.92,3.94-98.23,p<0.001)或入院时 CRP 为 40mg/L 或更高(OR 5.44,1.18-25.25;p = 0.030)。入院时症状持续超过 7 天的患者机械通气的可能性降低(0.087,95%CI 0.02-0.38,p = 0.001)。

结论

本研究为欧洲三级医院 SARS-CoV-2 感染患者的流行病学和临床过程提供了一些见解。年龄、男性、高 qSOFA 评分、CRP 为 40mg/L 或更高和双侧影像学浸润可帮助临床医生识别机械通气风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab5/7665644/569bf3a592dc/pone.0240781.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab5/7665644/569bf3a592dc/pone.0240781.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab5/7665644/569bf3a592dc/pone.0240781.g001.jpg

相似文献

1
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.瑞士一家大学医院中感染 SARS-CoV-2 的患者的流行病学、风险因素和临床病程:一项观察性回顾性研究。
PLoS One. 2020 Nov 13;15(11):e0240781. doi: 10.1371/journal.pone.0240781. eCollection 2020.
2
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
3
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
4
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
5
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
6
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局:一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.
7
Early prediction of level-of-care requirements in patients with COVID-19.对 COVID-19 患者的医疗照护需求进行早期预测。
Elife. 2020 Oct 12;9:e60519. doi: 10.7554/eLife.60519.
8
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
9
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
10
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection.临床虚弱量表用于 SARS-CoV-2 感染患者的风险分层。
J Investig Med. 2020 Aug;68(6):1199-1202. doi: 10.1136/jim-2020-001410. Epub 2020 Jul 7.

引用本文的文献

1
Importance of qSOFA Score in Terms of Prognosis and Mortality in Critical Care Patients.qSOFA评分在危重症患者预后和死亡率方面的重要性。
Yonago Acta Med. 2024 Aug 27;67(3):225-232. doi: 10.33160/yam.2024.08.009. eCollection 2024 Aug.
2
Associated Factors and Outcomes of Acute Kidney Injury in COVID-19 Patients in Kenya.肯尼亚新冠病毒肺炎患者急性肾损伤的相关因素及结局
Can J Kidney Health Dis. 2024 Jan 29;11:20543581241227015. doi: 10.1177/20543581241227015. eCollection 2024.
3
Dataset of single nucleotide polymorphisms of immune-associated genes in patients with SARS-CoV-2 infection.

本文引用的文献

1
Sex differences in immune responses that underlie COVID-19 disease outcomes.COVID-19 疾病结局相关的免疫反应中的性别差异。
Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26.
2
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局:一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.
3
Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan.
SARS-CoV-2 感染患者免疫相关基因单核苷酸多态性数据集。
PLoS One. 2023 Nov 16;18(11):e0287725. doi: 10.1371/journal.pone.0287725. eCollection 2023.
4
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.新冠病毒感染患者粪便微生物群的时间变化:一项纵向队列研究。
BMC Infect Dis. 2023 Aug 18;23(1):537. doi: 10.1186/s12879-023-08511-6.
5
Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 Infection.新型冠状病毒肺炎感染住院患者的临床特征及院内死亡的预测因素
J Clin Med. 2022 Dec 24;12(1):143. doi: 10.3390/jcm12010143.
6
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis.阿司匹林或其他抗血小板药物的使用与新冠肺炎患者全因死亡率之间的关联:一项荟萃分析。
Front Pharmacol. 2022 Oct 5;13:989903. doi: 10.3389/fphar.2022.989903. eCollection 2022.
7
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients.SARS-CoV-2 感染对癌症患者死亡率、入住 ICU 率和发病率的影响:一项涉及 709908 名参与者和 31732 例癌症患者的系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2023 Jul;149(7):2915-2928. doi: 10.1007/s00432-022-04191-y. Epub 2022 Jul 13.
8
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
9
Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis.肥胖或体重指数增加与 COVID-19 患者严重结局风险的关系:系统评价和荟萃分析方案。
Medicine (Baltimore). 2022 Jan 7;101(1):e28499. doi: 10.1097/MD.0000000000028499.
10
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.流感和 SARS-CoV-2 合并感染的致死率增加可被流感免疫预防,但不能被 SARS-CoV-2 免疫预防。
Nat Commun. 2021 Oct 5;12(1):5819. doi: 10.1038/s41467-021-26113-1.
新型冠状病毒肺炎患者管理中的有创机械通气:武汉469例患者的经验
Crit Care. 2020 Jun 16;24(1):348. doi: 10.1186/s13054-020-03044-9.
4
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.2020 年 2 月至 3 月,意大利佛罗伦萨传染病和热带病科在冠状病毒病(COVID-19)大流行期间的早期经验。
Euro Surveill. 2020 Apr;25(17). doi: 10.2807/1560-7917.ES.2020.25.17.2000556.
5
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
6
Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study.香港新冠肺炎危重症患者:一项多中心回顾性观察队列研究。
Crit Care Resusc. 2020 Apr 6;22(2):119-125. doi: 10.51893/2020.2.oa1.
7
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.85 例武汉 COVID-19 死亡病例的临床特征。一项回顾性观察研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379. doi: 10.1164/rccm.202003-0543OC.
8
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.宿主对重症新型冠状病毒肺炎的易感性及宿主风险评分的建立:武汉以外地区487例病例的研究结果
Crit Care. 2020 Mar 18;24(1):108. doi: 10.1186/s13054-020-2833-7.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.